SH2D1A
SH2D1A (SH2 domain containing 1A), also known as SAP, XLP and DSHP, is a small cytoplasmic adapter protein that regulates receptors of the signalling lymphocytic activation molecule (SLAM) family. It contributes to the bidirectional stimulation of T and B cells. Browse Assay Genie's current range of SH2D1A research reagents below, or read on for the biology behind the target.
SH2D1A is a cytoplasmic adapter that regulates receptors of the SLAM family, including SLAMF1, CD244, LY9, CD84, SLAMF6 and SLAMF7. In SLAM signalling it appears to cooperate with SH2D1B/EAT-2. An early model proposed that association with SLAMF1 prevents the receptor from binding inhibitory effectors such as INPP5D/SHIP1 and PTPN11/SHP-2. Later work showed that, through simultaneous interactions, SH2D1A recruits FYN, which then phosphorylates and activates SLAMF1.
In natural killer (NK) cells, SH2D1A positively regulates CD244/2B4- and CD84-mediated functions. It can also promote NK cell activation mediated by CD48, SLAMF6, LY9 and SLAMF7, and it enhances conjugate formation with target cells during NK cell-mediated cytotoxicity. It may also regulate the neurotrophin receptors NTRK1, NTRK2 and NTRK3. The protein consists of an SH2 domain and a short tail. It binds related surface molecules expressed on activated T, B and NK cells, and so modifies signal transduction in these cells. Researchers studying this pathway may work with the SH2D1A protein, an SH2D1A antibody or an SH2D1A ELISA kit.
The SH2D1A gene belongs to the SH2 domain containing gene group. Previous names include lymphoproliferative syndrome and SH2 domain protein 1A, and aliases include XLP, MTCP1, DSHP, XLPD, EBVS, IMD5 and LYP. Mutations in the gene cause X-linked lymphoproliferative syndrome type 1, or Duncan disease. This rare immunodeficiency is characterised by extreme susceptibility to Epstein-Barr virus infection, with severe mononucleosis and malignant lymphoma among the symptoms. Multiple transcript variants encoding different isoforms have been reported. Mouse and rat orthologs are both named Sh2d1a.
Mutations in SH2D1A cause X-linked lymphoproliferative syndrome type 1 (Duncan disease), making it central to studies of Epstein-Barr virus susceptibility.
SH2D1A positively regulates CD244- and CD84-mediated NK cell functions and enhances conjugate formation with target cells during cytotoxicity.
SH2D1A regulates SLAM family receptors by recruiting FYN and shaping access of inhibitory effectors such as SHP-2 and SHIP1.
SH2D1A plays a major role in the bidirectional stimulation of T and B cells and modifies signalling downstream of activated lymphocyte surface molecules.
SH2D1A is a cytoplasmic adapter that regulates SLAM family receptors on lymphocytes. It recruits FYN, which phosphorylates and activates SLAMF1, and it promotes NK cell functions mediated by receptors such as CD244 and CD84. It also modifies signalling in activated T, B and NK cells.
SH2D1A is also called SAP, for SLAM-associated protein, and has the aliases XLP, MTCP1, DSHP, XLPD, EBVS, IMD5 and LYP. Previous names include lymphoproliferative syndrome and SH2 domain protein 1A. Multiple transcript variants encoding different isoforms have been described.
Mutations in SH2D1A cause X-linked lymphoproliferative syndrome type 1, or Duncan disease, a rare immunodeficiency with extreme susceptibility to Epstein-Barr virus. Orthologs exist in mouse and rat, both named Sh2d1a. Check the datasheet of any product for its validated reactivity.
Other SH2 domain-containing adapters and signalling proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O60880; product specifications from Assay Genie datasheets.